Regulon

Regulon: R-1063

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
16-1.3744610Pr-134Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
5725 ENSG00000011304 PTBP1 A6NLN1
55205 ENSG00000074657 ZNF532 Q9HCE3
51729 ENSG00000084463 WBP11 Q9Y2W2
11198 ENSG00000092201 SUPT16H Q9Y5B9
10274 ENSG00000118007 STAG1 Q8WVM7
3609 ENSG00000129351 ILF3 A0A024R7C7
5894 ENSG00000132155 RAF1 A0A8I5KR46
3178 ENSG00000135486 HNRNPA1 P09651
5495 ENSG00000138032 PPM1B O75688
9879 ENSG00000145833 DDX46 Q7L014
5529 ENSG00000154001 PPP2R5E Q16537
26130 ENSG00000165219 GAPVD1 Q14C86
65110 ENSG00000169062 UPF3A Q9H1J1
10949 ENSG00000177733 HNRNPA0 Q13151
30849 ENSG00000196455 PIK3R4 Q99570
54870 ENSG00000198218 QRICH1 A1L3Z9

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
XL-281RAF1Small moleculeINHIBITORSerine/threonine-protein kinase RAF inhibitor20
SORAFENIB TOSYLATEPDGFRBSmall moleculeINHIBITORStem cell growth factor receptor inhibitor42
MLN-2480RAF1Small moleculeINHIBITORRAF serine/threonine protein kinase inhibitor10
SORAFENIBFLT3Small moleculeINHIBITORStem cell growth factor receptor inhibitor42
ARQ-736RAF1Small moleculeINHIBITORSerine/threonine-protein kinase RAF inhibitor10
LY-3009120ARAFSmall moleculeINHIBITORSerine/threonine-protein kinase A-Raf inhibitor10
LXH254RAF1Small moleculeINHIBITORB-raf/RAF proto-oncogene serine/threonine-protein kinase inhibitor20
REGORAFENIBKDRSmall moleculeINHIBITORTyrosine-protein kinase TIE-2 inhibitor42
BELVARAFENIBRAF1Small moleculeINHIBITORRAF serine/threonine protein kinase inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1063

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs